Business news – Page 63
-
Business
Lilly loses UK patent challenge
Allergan’s cancer drug generics do not infringe patents, say UK courts
-
Business
GSK fined for stalling antidepressant generics
UK Competition and Markets Authority deems pay-for-delay deal illegal and imposes £45m in fines
-
BusinessMylan to buy Meda in further generics consolidation
£6.9bn deal will give combined company ‘critical mass’ in US market
-
BusinessOil slump reverberates in chemicals
Collapse in crude prices has complex and mixed effects on markets for derivative chemicals
-
BusinessChemChina offers to buy Syngenta in $43bn takeover
Directors welcome deal that will allow agrochemicals giant to establish a presence in China
-
BusinessMedical devices consolidation continues
Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business
-
Business
BP to cut 7000 jobs
UK oil company reduces its workforce to cut costs in response to low oil price and charges from Deepwater Horizon incident
-
Business
Seed secrets thief jailed
Chinese born US citizen pleads guilty to conspiring to steal trade secrets from DuPont Pioneer and Monsanto
-
OpinionPride comes before a fall
In labs it’s important not to let familiarity breed complacency, says Derek Lowe
-
Business
Merck & Co joins hepatitis C party
New drug adds new treatment options and increases competition in premium market
-
BusinessJ&J to cut 3000 jobs in medical devices unit
Cost-saving cuts will help ‘accelerate the pace of innovation’, company claims
-
OpinionThe kids aren’t alright
Making it more attractive for companies to develop paediatric drugs has the potential to improve everyone’s lives
-
BusinessGSK scientists indicted for trade secret theft
Two researchers accused of passing research data and manufacturing details to Chinese firm
-
BusinessClinical trial death highlights hazards
Pain drug trial has left one dead and five hospitalised in France, with little indication as to the cause of the problems
-
Business
Fatal blast at US peroxide plant
One dead and three injured in an equipment explosion at PeroxyChem in Texas
-
BusinessCrispr goes commercial
Gene editing technique Crispr has shaken up genomics research and the commercial opportunities couldn’t be more evident
-
BusinessShire bets big on rare diseases
$32bn Baxalta buyout will deepen Shire’s commitment to developing specialist drugs for small patient populations
-
Business
ChemChina buys German machinery maker
Plastics and rubber equipment manufacturer KraussMaffei Group will retain German headquarters after €1bn deal
-
BusinessFixing the broken antibiotics business model
With rising resistance and doomsday warnings, focus is turning to alternative economic models to boost antibiotic R&D
-
Business
ThermoFisher will buy Affymetrix to expand genetic testing
Deal boosts Thermo’s position in growing genomics field as well as adding antibodies and assay technology